Literature DB >> 25120817

Characteristics of demyelinating Charcot-Marie-Tooth disease with concurrent diabetes mellitus.

Zhiliang Yu1, Xiaohua Wu2, Huijun Xie3, Ying Han2, Yangtai Guan3, Yong Qin2, Huimin Zheng3, Jianming Jiang3, Zhenmin Niu4.   

Abstract

PURPOSE: Charcot-Marie-Tooth disease (CMT) is the most common type of inherited peripheral neuropathy and has a high degree of genetic heterogeneity. CMT with concurrent diabetes mellitus (DM) is rare. The purpose of this study is to explore the genetic, clinical and pathological characteristics of the patients with CMT and concurrent DM.
METHODS: We investigated gene mutations (the peripheral myelin protein 22 gene, myelin protein zero gene, lipopolysaccharide-induced tumor necrosis factor-α factor gene, early growth response gene and the neurofilament light chain gene loci) of a relatively large and typical Chinese family with CMT1 and concurrent DM2. From the literature, we also retrieved all reported families and single cases with CMT and concurrent DM. We comprehensively analyzed the characteristics of total 33 patients with CMT and concurrent DM, and further compared these characteristics with those of patients of diabetic peripheral neuropathy (DPN).
RESULTS: Patients with CMT and concurrent DM had some relatively independent characteristics and pathogenic mechanisms. So we designated that kind of characteristic demyelinating CMT which accompanies DM as Yu-Xie syndrome (YXS), a new specific clinical subtype of CMT.
CONCLUSION: CMT is an etiologic factor of DM, even though the intrinsic association between CMT and DM still remains further exploration.

Entities:  

Keywords:  Charcot-Marie-Tooth disease; Yu-Xie syndrome; diabetes mellitus; pedigree analysis

Mesh:

Year:  2014        PMID: 25120817      PMCID: PMC4129052     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  34 in total

1.  Charcot-Marie-Tooth disease associated with Type 2 diabetes mellitus.

Authors:  M Celik; H Forta; Y Parman; N Bissar-Tadmouri; K Demirkirkan; E Battaloglu
Journal:  Diabet Med       Date:  2001-08       Impact factor: 4.359

2.  Polymorphic short tandem repeats for diagnosis of the Charcot-Marie-Tooth 1A duplication.

Authors:  P Latour; L Boutrand; N Levy; R Bernard; A Boyer; F Claustrat; G Chazot; M Boucherat; A Vandenberghe
Journal:  Clin Chem       Date:  2001-05       Impact factor: 8.327

3.  EGR2 mutation R359W causes a spectrum of Dejerine-Sottas neuropathy.

Authors:  C F Boerkoel; H Takashima; C A Bacino; D Daentl; J R Lupski
Journal:  Neurogenetics       Date:  2001-07       Impact factor: 2.660

4.  Neurodegeneration is associated to changes in serum insulin-like growth factors.

Authors:  S Busiguina; A M Fernandez; V Barrios; R Clark; D L Tolbert; J Berciano; I Torres-Aleman
Journal:  Neurobiol Dis       Date:  2000-12       Impact factor: 5.996

5.  Deafness and CMT disease associated with a novel four amino acid deletion in the PMP22 gene.

Authors:  Nyamkhishig Sambuughin; Astrid de Bantel; Shona McWilliams; Kumaraswamy Sivakumar
Journal:  Neurology       Date:  2003-02-11       Impact factor: 9.910

6.  Influence of comorbidities on the phenotype of patients affected by Charcot-Marie-Tooth neuropathy type 1A.

Authors:  Giulia Ursino; M Antonia Alberti; Marina Grandis; Lizia Reni; Davide Pareyson; Emilia Bellone; Chiara Gemelli; Mario Sabatelli; Chiara Pisciotta; Marco Luigetti; Lucio Santoro; Laura Massollo; Angelo Schenone
Journal:  Neuromuscul Disord       Date:  2013-07-23       Impact factor: 4.296

7.  Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease.

Authors:  A Jordanova; P De Jonghe; C F Boerkoel; H Takashima; E De Vriendt; C Ceuterick; J-J Martin; I J Butler; P Mancias; S Ch Papasozomenos; D Terespolsky; L Potocki; C W Brown; M Shy; D A Rita; I Tournev; I Kremensky; J R Lupski; V Timmerman
Journal:  Brain       Date:  2003-03       Impact factor: 13.501

8.  [A case of Charcot-Marie-Tooth disease (CMT) type 1 complicated by diabetes mellitus (DM) showing bilateral phrenic nerve palsy].

Authors:  Yuka Takakura; Hirokazu Furuya; Ken-ichiro Yamashita; Hiroyuki Murai; Takehisa Araki; Hitoshi Kikuchi; Yasumasa Ohyagi; Takeshi Yamada; Jun-ichi Kira
Journal:  Rinsho Shinkeigaku       Date:  2002-04

9.  Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C.

Authors:  V A Street; C L Bennett; J D Goldy; A J Shirk; K A Kleopa; B L Tempel; H P Lipe; S S Scherer; T D Bird; P F Chance
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910

Review 10.  Electrophysiologic measures of diabetic neuropathy: mechanism and meaning.

Authors:  Joseph C Arezzo; Elena Zotova
Journal:  Int Rev Neurobiol       Date:  2002       Impact factor: 3.230

View more
  3 in total

1.  A case report of hereditary neuropathy with liability to pressure palsies accompanied by type 2 diabetes mellitus and psoriasis.

Authors:  Jing Li; Bing Niu; Xiaoling Wang; Huaiqiang Hu; Bingzhen Cao
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

2.  A Novel Synergistic Association of Variants in PTRH2 and KIF1A Relates to a Syndrome of Hereditary Axonopathy, Outer Hair Cell Dysfunction, Intellectual Disability, Pancreatic Lipomatosis, Diabetes, Cerebellar Atrophy, and Vertebral Artery Hypoplasia.

Authors:  S Charles Bronson; E Suresh; S Stephen Abraham Suresh Kumar; C Mythili; A Shanmugam
Journal:  Cureus       Date:  2021-02-06

3.  Dynamin deficiency causes insulin secretion failure and hyperglycemia.

Authors:  Fan Fan; Yumei Wu; Manami Hara; Adam Rizk; Chen Ji; Dan Nerad; Natalia Tamarina; Xuelin Lou
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-10       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.